Status:
COMPLETED
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function
Lead Sponsor:
Izmir Bakircay University
Conditions:
Cancer
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18-85 years
Brief Summary
As cancer survival rates have been increased due to technological developments and early detection strategies, there has been been a growing need to assess the effect of long-term complications and ad...
Detailed Description
Chemotherapy-induced peripheral neuropathy (CIPN) which affects over 30-40% of patients with cancer undergoing chemotherapy cause cutaneous loss of sensation. A specific and selective function carries...
Eligibility Criteria
Inclusion
- Being a Volunteer to participate this study
- Having diagnosed with Cancer
- Having available to be implemented to adjuvant systemic chemotherapy application
Exclusion
- Prior diagnosed with diabetic polyneuropathy
- Neo-adjuvant chemotherapy
- Having scar tissue in the palmar and/or plantar side(s) of the skin might affect the sensory evaluation
- Having Multiple Sclerosis or other neurological diseases which might affect neural conductivity disturbances and/or sensory loss
Key Trial Info
Start Date :
March 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04799080
Start Date
March 6 2021
End Date
May 15 2022
Last Update
April 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bakircay University Çiğli State and Training Hospital, Department of Medical Oncology
Izmir, Çiğli, Turkey (Türkiye), 35620